NYSE$KVUE
Kenvue Inc · Q1 2026 earnings
Q1 2026 earnings · · Before market open · Investor relations
Briefing
Kenvue Inc Q1 fiscal 2026: $3.91B revenue, $474.0M net income
net losses to J&J, the Company will reimburse J&J for the amount of such net losses). (SEC accession 0001944048-26-000098)
- Revenue: $3.91B
- Net income: $474.0M
- Diluted EPS: $0.25
- Operating income: $767.0M
- Gross profit: $2.30B
Headline financials
Revenue & EPS history
Kenvue · Revenue · Quarterly
$3.91B
Revenue by segment
Kenvue · $3.92B total across 3 segments · Q3 2023
- Self Care$1.61B+6.4%41.2%
- Essential Health$1.18B+3.0%30.2%
- Skin Health & Beauty$1.12B-0.4%28.6%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 12 quarterly earnings reports · overlaid with Q1 2026
+2.0%
Avg return
Earnings day
+3.1%
Avg return
5 days after
+3.0%
Avg return
30 days after
57%
8 / 14 earnings
Positive
+15.7%
Q3 2025
Best reaction
-7.7%
Q3 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +2.0% | -1.2% | — | |
| Q4 2025 | +0.9% | +2.9% | -5.5% | |
| Q3 2025 | +15.7% | +17.5% | +18.1% | |
| Q2 2025 | +1.5% | +2.1% | -13.2% | |
| Q1 2025 | +4.3% | +2.4% | -6.0% | |
| Q4 2024 | -4.5% | +0.8% | +12.9% | |
| Q3 2024 | +5.2% | +5.1% | +1.5% | |
| Q2 2024 | +13.4% | +15.6% | +23.7% | |
| Q1 2024 | +7.2% | +7.7% | -2.4% | |
| Q4 2022 | -0.2% | +3.1% | +12.9% | |
| Q4 2023 | -5.8% | -6.2% | -2.4% | |
| Q3 2023 | -7.7% | -5.7% | +2.6% | |
| Q2 2023 | -4.0% | +0.5% | -8.5% | |
| Q1 2023 | -0.5% | -0.8% | +4.5% | |
| Q3 2022 | — | — | — | |
| Q2 2022 | — | — | — | |
| Q1 2022 | — | — | — | |
| Q4 2021 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro